DIAGNOSTIC DIFFICULTIES: SUDDEN VISUAL LOSS IN GIANT CELL ARTERITIS


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Giant cell arteritis ran predominantly involving the ophthalmic arteries in the described clinical observation. Thorough collection of history data and evaluation of the clinical symptoms of the disease in conjunction with the results of up-to-date instrumental studies have allowed a correct diagnosis.

Full Text

Restricted Access

About the authors

N. Chichkova

I.M. Sechenov First Moscow State Medical University

Email: nvchichkova@mail.ru
V.N. Vinogradov Faculty Therapy Clinic University Clinical Hospital One Professor , MD

V. Sulimov

I.M. Sechenov First Moscow State Medical University

V.N. Vinogradov Faculty Therapy Clinic University Clinical Hospital One Professor , MD

I. Shchedrina

I.M. Sechenov First Moscow State Medical University

V.N. Vinogradov Faculty Therapy Clinic University Clinical Hospital One Candidate of Medical Sciences

E. Pavlenko

I.M. Sechenov First Moscow State Medical University

V.N. Vinogradov Faculty Therapy Clinic University Clinical Hospital One

N. Fisenko

I.M. Sechenov First Moscow State Medical University

V.N. Vinogradov Faculty Therapy Clinic University Clinical Hospital One

References

  1. Бунчук Н.В. Ревматические заболевания пожилых / М.: МЕДпресс-информ, 2010; с. 6-136.
  2. Новиков П.И., Семенкова Е.Н., Моисеев С.В. Современная номенклатура системных васкулитов // Клин. фармакол. и терапия. - 2013; 1: 70-5.
  3. Оттева Э. Ревматическая полимиалгия и гигантоклеточный артериит: клиника, диагностика, мониторинг, лечение // Лечение и профилактика. -2013; 3 (7): 130-9.
  4. Ревматология. Клинические рекомендации (ред. Насонов Е.Л.) / М.: ГЭОТАР-Медиа, 2008.
  5. Borchers A., Gershwin M. Giant cell arteritis: A review of classification, pathophysiology, geoepidemiology and treatment // Autoimmunity Reviews. -2012; 11: 544-54.
  6. Chew S., Kerr N., Danesh-Meyer H. Giant cell arteritis // J. Clin. Neuroscience. - 2009; 16: 1263-8
  7. Devauchelle-Pensec V., Jousse S., Destombe C. et al. Epidemiology, imaging, and treatment of giant cell arteritis // Joint. Bone S. - 2008; 75: 267-72.
  8. Espitia O., Agard C. Aortite et complications aortiques de l’artérite à cellules géantes (maladie de Horton) // Rev. Med. Interne. - 2013; 34 (7): 412-20.
  9. Gonzalez-Gay M., Vazquez-Rodriguez T., Lopez-Diaz M. et al. Epidemiology of giant cell arteritis and polymyalgia rheumatic // Arthritis Rheum. - 2009; 61: 1454-61.
  10. Hayreh S., Podhajsky P., Zimmerman B. Ocular manifestations of giant cell arteritis // Am. J. Ophthalmol. - 1998; 125: 509-20.
  11. Kim-Heang L., Régent A., Tamby M. et al. Pathogenesis of giant cell arteritis: More than just an inflammatory condition? // Autoimmunity Reviews. -2010; 9: 635-45.
  12. Mackie S., Pease C. Diagnosis and management of giant cell arteritisand polymyalgia rheumatica: challenges,controversies and practical tips // Postgrad. Med. J. - 2013; 89 (1051): 284-92. doi: 10.1136/postgradmedj-2012-131400
  13. Martinez-Taboada V., Alvarez L., RuizSoto M. et al. Giant cell arteritis and polymyalgia rheumatica: Role of cytokines in the pathogenesis and implications for treatment // Cytokine. - 2008; 44: 207-20.
  14. Masson Ch. Therapeutic approach to giant cell arteritis // Joint Bone Spine. - 2012; 79: 219-27.
  15. Patel M. et al. Polymyalgia rheumatica and giant cell arteritis // J. Clin. Gerontol. Geriatr. - 2011; 2: 7-12.
  16. Pipitone N., Salvarani C. Update on polymyalgia rheumatica // Eur. J. Intern. Med. - 2013; 24 (1): 583-9.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies